Actively Recruiting
Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)
Led by Guangzhou Burning Rock Dx Co., Ltd. · Updated on 2022-07-06
12500
Participants Needed
1
Research Sites
343 weeks
Total Duration
On this page
Sponsors
G
Guangzhou Burning Rock Dx Co., Ltd.
Lead Sponsor
W
West China Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
PREVENT is a prospective, multicenter, interventional study evaluating the performance of the OverC multi-cancer detection blood test in asymptomatic individuals with cancer risk.
CONDITIONS
Official Title
Multi-canceR Early-detection Test in Asymptomatic Individuals (PREVENT)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participants must be able to provide a written informed consent form
- Participants must not have had a colonoscopy, abdominal MRI/CT, low-dose CT, or chest CT within 5 years before consent
- Participants must be able to provide blood samples for study tests
- Participants must be between 40 and 75 years old
You will not qualify if you...
- Individuals with an acute infection or inflammation within 14 days before recruitment
- Individuals with cancer-related symptoms or suspected cancer
- Recipients of organ transplant or prior non-autologous bone marrow or stem cell transplant
- Recipients of blood transfusion within 7 days before recruitment
- Individuals with pure ground-glass opacity
- Unable to provide blood samples for the multi-cancer detection test
- Unable to tolerate or have contraindications to standard cancer screening tests
- Taken anti-tumor medication within 30 days before recruitment
- Received or undergoing curative cancer treatment within 3 years before recruitment
- Individuals with bleeding disorders
- Individuals with autoimmune diseases
- Pregnant or lactating individuals
- Individuals with severe comorbidities unsuitable for trial participation as judged by researchers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610044
Actively Recruiting
Research Team
S
Shangli Cai
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here